Bridge the Gap

NewBridge's global business network and unique value proposition provide a platform to bridge the access gap of global innovation and successful reach within the MENA region
Accessing Innovation

NewBridge - a specialty company providing a one stop solution to pharmaceutics, biological, genomics and other innovative healthcare companies seeking to access the MENA markets.
Serving Patients

NewBridge is committed to providing advanced treatment options through innovative healthcare products to bridge the unmet medical needs of patients in the MENA region

LATEST NEWS

November 18, 2021

BioCryst Announces Approval of ORLADEYO® (berotralstat) in United Arab Emirates

Company selects NewBridge Pharmaceuticals as regional distributor in Gulf Cooperation Council RESEARCH TRIANGLE PARK, N.C.,...

November 14, 2021

BeiGene and NewBridge Pharmaceuticals Announce Approval in Saudi Arabia of BRUKINSA® (Zanubrutinib) for the Treatment of Patients with Relapsed or Refractory Mantle Cell Lymphoma

BeiGene and NewBridge Pharmaceuticals are working together to rapidly advance BRUKINSA in the Middle East and North African (MENA) region...

July 20, 2021

Pharming signs agreement with NewBridge Pharmaceuticals for the commercialization of RUCONEST® in the Middle East and North Africa

Pharming Group N.V. (“Pharming” or “the Company”) (Euronext Amsterdam: PHARM/Nasdaq: PHAR) announces it has entered...

Accessing Innovation, Serving Patients

NewBridge's global business network, unique value proposition, and its one-stop solution to pharmaceutical, biologics, genomics and other innovative healthcare companies provide a platform both for accessing global innovation – and ensuring successful reach within the MENA Region. NewBridge is committed to bridge the unmet medical needs of, and provide advanced treatment to patients in the Region.

ABOUT NEWBRIDGE

NewBridge provides essential access to build value for pharmaceutics and biotech companies.

learn more

WHY PARTNER WITH US

NewBridge provides access to innovative therapeutics and diagnostics for patients in the MENA Region

learn more

OUR PRODUCTS

NewBridge has a commercial presence covering 20 plus countries in its network in the MENA Region

learn more

WHO WE ARE AND WHAT WE DO

NewBridge is a regional specialty company providing a one-stop-solution to pharmaceutics, biological, genomics and other innovative healthcare companies.

Our focus is on in-licensing and commercializing FDA and EMA/European approved innovative therapeutics and diagnostics that address unmet medical needs of diseases with high prevalence within the MENA region.

Our business model is designed to provide the partners we represent with a full range of services and multiple functions to bring long term commercial excellence and build value to our licensed brands across multiple geographies.

Our success is driven by highly talented teams who come to NewBridge with a proven track record and experience in the pharmaceutical industry regionally and globally.